CORDANI NICOLETTA

Villa, M., Malighetti, F., Villa, A., Cordani, N., Aroldi, A., Zambon, A., et al. (2026). Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models. JOURNAL OF TRANSLATIONAL MEDICINE [10.1186/s12967-026-08420-7]. Dettaglio

Malighetti, F., Civettini, I., Aroldi, A., Villa, A., Villa, M., Sala, L., et al. (2026). Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations. BIOINFORMATICS, 42(Supplement_2) [10.1093/bioinformatics/btag491]. Dettaglio

Crippa, V., Cordani, N., Villa, A., Malighetti, F., Villa, M., Sala, L., et al. (2025). Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) [Altro] [10.1038/s41698-025-01114-1]. Dettaglio

Malighetti, F., Villa, M., Villa, A., Pelucchi, S., Aroldi, A., Cortinovis, D., et al. (2025). Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(5) [10.3390/ijms26051943]. Dettaglio

Villa, M., Malighetti, F., De, S., Villa, A., Cordani, N., Aroldi, A., et al. (2025). Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors. NUCLEIC ACIDS RESEARCH, 53(13 (22 July 2025)) [10.1093/nar/gkaf648]. Dettaglio